Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Enzolinion Jan 15, 2019 3:53pm
200 Views
Post# 29235913

I calling BS!!!!

I calling BS!!!!
Penny! I was with you till last week. I've also talked to Robert about 10 times from last july when he mentiond spmething in regards to a Canadian LP and today still nothing. But payments to salzman(monthly) and PP have been taking place almost monthly, but if you look up Kalytera its address was a house and finally now its an office.  I've been holding over a year now and the only thing it's done is go down. Ecellon comes in and puts a target of .30 cents??? Anyone could of said that. We also have people believing what these losers have hired saying they have had companies that went from .40 cents to 40 dollars over night!! Wake up people and maybe start thinking that Robert is a fool and is taking all of us for a ride.  Notice the stock is being played it wont go over .10 cents, I really wish i could get out but i'm in way to high.  Again people buy with caution...
Bullboard Posts